Insights

Strategic Portfolio Expansion BioMarin's recent integration with Amicus Therapeutics and its investments in expanding research and manufacturing facilities in Ireland indicate a focus on broadening its rare disease portfolio and increasing production capacity, presenting opportunities to collaborate on new therapies and supply chain solutions.

Pipeline & Innovation Focus With a pipeline of multiple product candidates and a history of successful first-in-class treatments, BioMarin is continually seeking innovative solutions, offering potential for partnership in advancing novel genetic therapies and expanding market reach.

Financial Growth & Investment Generating over a billion dollars in revenue and investing hundreds of millions into infrastructure, BioMarin signals strong financial health and commitment to growth, making it a viable partner for technology providers, R&D collaborations, and service solutions.

Market Leadership & Expertise As a leading biotech company with a patient-centered approach and a focus on rare genetic diseases, BioMarin provides opportunities to co-develop targeted therapies, clinical research support, and specialized healthcare solutions aligned with a niche but expanding market.

Regulatory & Compliance Readiness BioMarin's rigorous recruitment and compliance practices, along with its international expansion, highlight an openness to technological integrations that enhance regulatory adherence and operational efficiency, offering opportunities for solution providers in compliance and security domains.

BioMarin Pharmaceutical Inc. Tech Stack

BioMarin Pharmaceutical Inc. uses 8 technology products and services including CIM Technologies, Squarespace, Monte Carlo, and more. Explore BioMarin Pharmaceutical Inc.'s tech stack below.

  • CIM Technologies
    Cad & Graphics
  • Squarespace
    Content Management System
  • Monte Carlo
    Data Management Platforms
  • Module Federation
    Development
  • Hootsuite
    Marketing
  • GEP Smart
    Procurement
  • Base SAS
    Software As A Service
  • Ativo
    Ticket Booking

Media & News

BioMarin Pharmaceutical Inc.'s Email Address Formats

BioMarin Pharmaceutical Inc. uses at least 2 format(s):
BioMarin Pharmaceutical Inc. Email FormatsExamplePercentage
First.Last@bmrn.comJohn.Doe@bmrn.com
63%
FLast@bmrn.comJDoe@bmrn.com
32%
Last.First@bmrn.comDoe.John@bmrn.com
2%
First.Middle@bmrn.comJohn.Michael@bmrn.com
1%
FiLast@bmrn.comJoDoe@bmrn.com
1%
FL@bmrn.comJD@bmrn.com
1%
First.Last@biomarin.comJohn.Doe@biomarin.com
87%
FLast@biomarin.comJDoe@biomarin.com
13%

Frequently Asked Questions

What is BioMarin Pharmaceutical Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact BioMarin Pharmaceutical Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is BioMarin Pharmaceutical Inc.'s stock symbol?

Minus sign iconPlus sign icon
BioMarin Pharmaceutical Inc. is a publicly traded company; the company's stock symbol is BMRN.

What is BioMarin Pharmaceutical Inc.'s official website and social media links?

Minus sign iconPlus sign icon
BioMarin Pharmaceutical Inc.'s official website is biomarin.com and has social profiles on LinkedInCrunchbase.

How much revenue does BioMarin Pharmaceutical Inc. generate?

Minus sign iconPlus sign icon
As of December 2025, BioMarin Pharmaceutical Inc.'s annual revenue is estimated to be $1.5B.

What is BioMarin Pharmaceutical Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
BioMarin Pharmaceutical Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BioMarin Pharmaceutical Inc. have currently?

Minus sign iconPlus sign icon
As of December 2025, BioMarin Pharmaceutical Inc. has approximately 3.1K employees across 6 continents, including North AmericaEuropeSouth America. Key team members include Chief Information Officer: E. V. P.Vp Head Of Enzymes And Metabolic Disease Research: P. A.Vice President Global Commercial Operations - Business Operations & Strategy: E. O.. Explore BioMarin Pharmaceutical Inc.'s employee directory with LeadIQ.

What industry does BioMarin Pharmaceutical Inc. belong to?

Minus sign iconPlus sign icon
BioMarin Pharmaceutical Inc. operates in the Biotechnology Research industry.

What technology does BioMarin Pharmaceutical Inc. use?

Minus sign iconPlus sign icon
BioMarin Pharmaceutical Inc.'s tech stack includes CIM TechnologiesSquarespaceMonte CarloModule FederationHootsuiteGEP SmartBase SASAtivo.

What is BioMarin Pharmaceutical Inc.'s email format?

Minus sign iconPlus sign icon
BioMarin Pharmaceutical Inc.'s email format typically follows the pattern of First.Last@bmrn.com. Find more BioMarin Pharmaceutical Inc. email formats with LeadIQ.

How much funding has BioMarin Pharmaceutical Inc. raised to date?

Minus sign iconPlus sign icon
As of December 2025, BioMarin Pharmaceutical Inc. has raised $586M in funding. The last funding round occurred on May 11, 2020 for $586M.

When was BioMarin Pharmaceutical Inc. founded?

Minus sign iconPlus sign icon
BioMarin Pharmaceutical Inc. was founded in 1997.

BioMarin Pharmaceutical Inc.

Biotechnology ResearchCalifornia, United States1001-5000 Employees

Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. The company develops and commercializes targeted therapies that address the root cause of the genetic conditions that it seeks to treat, helping to better the lives of those struggling with rare genetic disease. BioMarin discoveries have led to eight first or best-in-class commercial treatments and a pipeline of multiple product candidates applying the same science-driven, patient-forward approach to broader group of genetic disorders. The more innovative solutions developed, the more lives BioMarin can impact.


Recruitment Fraud Alert Notice
 
Please be aware of fraud or scams from individuals, organizations and/or internet sites claiming to represent BioMarin in recruitment activities. We have an established recruitment process which is required for all posted positions by BioMarin prior to issuing an offer of employment. This BioMarin process requires formal interviews conducted live with personnel representing BioMarin and never requires payments or fees from job applicants. BioMarin does not conduct interviews via texting tools such as RingCentral.
 
In the event you receive a suspicious email message about recruiting on behalf of BioMarin, unless it’s from a BioMarin authorized recruiting partner, do not provide any personal information or pay any fees. Qualified and interested candidates should apply to current openings directly through this BioMarin website. BioMarin accepts no responsibility for any costs or charges incurred as a result of fraudulent activity.
 
If you have lost money or provided your personal identifying information, please contact your bank and report the matter to the FBI via www.ic3.gov. We would also suggest you notify your local police department and monitor your credit.

We appreciate your interest in BioMarin & encourage you to visit http://careers.biomarin.com/career-areas to review job opportunities.

Section iconCompany Overview

Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
BMRN
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1997
Employees
1001-5000

Section iconFunding & Financials

  • $586M

    BioMarin Pharmaceutical Inc. has raised a total of $586M of funding over 1 rounds. Their latest funding round was raised on May 11, 2020 in the amount of $586M.

  • $1B$10B

    BioMarin Pharmaceutical Inc.'s revenue is estimated to be in the range of $1B$10B

Section iconFunding & Financials

  • $586M

    BioMarin Pharmaceutical Inc. has raised a total of $586M of funding over 1 rounds. Their latest funding round was raised on May 11, 2020 in the amount of $586M.

  • $1B$10B

    BioMarin Pharmaceutical Inc.'s revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.